Olferatx
1 known investors
Olfera develops biopharmaceutical treatments for neurological conditions that use the olfactory system as a non-invasive pathway to the brain, bypassing the blood-brain barrier. Its platform is used to discover, optimize, and deliver drugs, converting existing FDA-approved and candidate neurological drugs into easier-to-administer therapies.
Investors · 1
Frequently asked questions
- What does Olferatx do?
- Olfera develops biopharmaceutical treatments for neurological conditions that use the olfactory system as a non-invasive pathway to the brain, bypassing the blood-brain barrier. Its platform is used to discover, optimize, and deliver drugs, converting existing FDA-approved and candidate neurological drugs into easier-to-administer therapies.
- Who are Olferatx's investors?
- Olferatx's investors include E2MC Ventures.